Solas Bioventures Management, LLC
USA based Venture Capital firm that invests exclusively in the Life Science industry
In the firm's own words, from its website.
2 additional team members, 11 additional co-investors and affiliates, 36 additional investments, funds and LPs, 1 event, 1 verified contact (1 firm phone)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 180 days.
People to know
View all people- ManagerWhy: Named with investment responsibilityNo route on file yet
- ManagerWhy: Named with investment responsibilityNo route on file yet
- ManagerWhy: Named with investment responsibilityNo route on file yet
Relationship network
61 connected entities4 observed rounds1 repeat counterparty
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Fund or vehicle
- Person
›How strength and recency are read
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Solas Bioventures Management, LLC: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Solas Bioventures Management, LLC
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
30 companies on record, 0 new in 12 months
Investments on record
What these amounts mean“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.Acquired, Public, Exited and Active are what the firm’s own portfolio card says, read on the date shown when you hover the chip; they are not deal dates. A company with no chip is one whose card states no outcome: DFX does not assume it is active.| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Aegea | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Firm website |
| ARRIVO Resized | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Firm website |
| baebies inc. | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Firm website |
Stated thesis versus observed behaviour
- Sectors
- healthcare, biotech, medtech, space
- Stages
- early
- Geography
- tennessee, usa, worldwide
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Team
5 current, 0 departed
Decision makers
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
Investment team
How the team is orderedPartners who lead rounds first (rounds led, then deals attributed, then seniority), then the rest of the investment team, then investor relations, finance and operations. A person named by two sources under two spellings is shown once.- Manager · 3 deals attributed
- Manager · 1 deal attributed
- Manager
Contacts
1 firm phone on record, each with its source. Values open with the complete profile.
Funds and LPs
12 vehicles, 0 LPs disclosed
Funds and vehicles
What these amounts meanGAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Solas Intershunt Sidecar LLC | SPV or co-invest vehicle | 2024 form d first sale | Early deployment | $1.5M Sep 12, 2026 | 24 | $1.4M | Jan 16, 2025 |
| Solas Tvardi Sidecar LLC | SPV or co-invest vehicle | 2024 form d first sale | Newly closed | $567,443 Sep 12, 2026 | 64 | $13.3M | Jan 16, 2025 |
| Solas Basking Holdings, LLC | Fund | 2023 form d first sale | Active deployment | $9.0M Sep 12, 2026 | 63 | $9.0M | Jul 30, 2024 |
Limited partners
Known LPs and allocators
What these amounts and dates areEach commitment is counted once across the pension tape and the allocator graph. A commitment date prints only when the source printed one; otherwise the row carries the report date. A foundation’s 990-PF line is a holding at fair value, never a commitment. Rows without a fund on the venture graph are commitments to this manager.Relationships across DFX
14 co-investors · on 1 other DFX graph
Co-investors
- 2026-10-011 shared deal · one time
- 2026-10-011 shared deal · one time
- 2026-09-301 shared deal · one time
Across DFX and the capital chainon 1 other DFX graph ShowHide
- The same institution is held on RIA and Wealth, matched by identifier. See which records
Solas Bioventures Management, LLC is the same institution as 1 record in RIA and Wealth.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Evidence and history
6 dated events, 30 observations from 3 sources
Timeline
- Sep 12, 2026Solas Maclellan Group Jv first reported on Form ADV by Solas Bioventures Management, LLC, GAV $12,256,344
- Sep 12, 2026Solas Bioventures Fund II, LP first reported on Form ADV by Solas Bioventures Management, LLC, GAV $28,703,745
- Sep 12, 2026Solas Bioventures Fund I, LP first reported on Form ADV by Solas Bioventures Management, LLC, GAV $10,642,863
- Sep 12, 2026Solas Bioventures Emerging Healthcare Fund, LP first reported on Form ADV by Solas Bioventures Management, LLC, GAV $48,641,749
- Sep 12, 2026Solas Arrivo B Sidecar first reported on Form ADV by Solas Bioventures Management, LLC, GAV $1,846,665
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Jul 30, 2026 · 12 private fundsShowHide
- Headquarters
- Chattanooga, TNadviserinfo.sec.gov
- Office address
- unknownadviserinfo.sec.gov
- Business phone
- unknownadviserinfo.sec.gov
- Website
- solasbio.com
- SEC adviser type
- Registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Jul 30, 2026
- Private funds reported
- 12 (12 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $165Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $165Mthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 6
- Owners on Schedule A
- Risky Business LLC (Member), owns under 5%
Classification history
Classification history
Every classification this record has carried2 on recordShowHide
- Sep 13, 2026Institutional venture firm (probable, 80%)Venture manager, reported GAV $165M across 12 vehicles
- Sep 12, 2026Institutional venture firm (probable, 70%)Venture manager with no reported fund assets yet (scale unknown)
Evidence
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | VC funds reported | Jul 30, 2026 | Fact | Form ADV |
| SEC adviser type | Registered investment adviser | Jul 30, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-07-30 | Jul 30, 2026 | Fact | Form ADV |
| Adv pdf loaded | adv-pdf-1 | Sep 12, 2026 | Fact | Form ADV |
| SEC status | Approved | Jul 30, 2026 | Fact | Form ADV |
| SEC status effective | 2025-11-19 | Jul 30, 2026 | Fact | Form ADV |
| Business phone | Jul 30, 2026 | Fact | Form ADV | |
| Description | Sep 16, 2026 | Fact | ||
| Description | Sep 14, 2026 | Fact | ||
| Employees | 6 | Jul 30, 2026 | Fact | Form ADV |
| Headquarters | Chattanooga, TN | Jul 30, 2026 | Fact | Form ADV |
| Office address | Jul 30, 2026 | Fact | Form ADV | |
| Self-described type | Venture capital | Sep 16, 2026 | Fact | |
| Self-described type | Venture capital | Sep 14, 2026 | Fact | |
| Legal form | Limited Liability Company | Jul 30, 2026 | Fact | Form ADV |
| Portfolio page | Sep 16, 2026 | Fact | ||
| Portfolio page | Sep 14, 2026 | Fact | ||
| Private funds reported | 12 | Jul 30, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $165M | Jul 30, 2026 | Fact | Form ADV |
| Regulatory AUM (adviser, not fund size) | $165M | Jul 30, 2026 | Fact | Form ADV |
| Stated geography | Tennessee, usa, worldwide “geography words on the home page” | Sep 16, 2026 | Fact | |
| Stated geography | Tennessee, usa, worldwide “geography words on the home page” | Sep 14, 2026 | Fact | |
| Stated sectors | Healthcare, biotech, medtech, space “sector words on the home page” | Sep 16, 2026 | Fact | |
| Stated sectors | Healthcare, biotech, medtech, space “sector words on the home page” | Sep 14, 2026 | Fact | |
| Stated stages | early “stage words on the home page” | Sep 16, 2026 | Fact | |
| Stated stages | early “stage words on the home page” | Sep 14, 2026 | Fact | |
| Venture funds reported | 12 | Jul 30, 2026 | Fact | Form ADV |
| Website | Jul 30, 2026 | Fact | Form ADV | |
| Site title | Sep 16, 2026 | Fact | ||
| Site title | Sep 14, 2026 | Fact |
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, probableShowHide
Venture manager, reported GAV $165M across 12 vehicles
- importance
- gav: 0.37 · funds: 1 · people: 0.16 · investments: 0.56 · co investors: 0.46
- active deployment
- investments 12m: 0 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 1 · latest investment at: not scored
- emerging manager
- fund count: 12 · reported gav: $165M · first adv filing: 2025-11-19 · years since first filing: 0.9
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Record history
- Adviser's first ADV filing2025-11-19source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.